Even subtle symptoms may herald serious conditions. If missed on eye exams, they can have life-threatening consequences. Medscape Ophthalmology
Author: Medscape
Burnout Rises Above 50% in Some Specialties, New Survey Shows
Urologists had the highest burnout rates; 20% of all physicians said they have had thoughts of suicide or prefer not to answer. Medscape Medical News
Can Medical Marijuana Help Your Practice Thrive?
With more acceptance by states and interest by patients, the use of medical cannabis is growing. But there is a lot physicians need to know before considering a recommendation for treatment. Medscape Business of Medicine
Take Diabetes Into Consideration When Assessing for Glaucoma
Diabetes and hyperglycemia are associated with thicker central corneal thickness, a relationship that could lead to overestimation of intraocular pressure, researchers warn ophthalmologists. Medscape Medical News
FDA Clears Novel Eye Tracking Test to Detect Concussion
EyeBOX is the first noninvasive, baseline-free test to help in the diagnosis of concussion. The 4-minute test is appropriate for ages 5 to 67 years. FDA Approvals
Errors in Diagnosing Optic Neuritis–How Can We Fix Them?
A new study sheds light on the alarmingly high rate of misdiagnosis–and misallocated treatments–in this acute condition. Medscape Optometry
Diplopia and Upper Eyelid Ptosis in a 74-Year-Old Man
A 74-year-old man presents with variable diplopia and ptosis of the left upper eyelid. What is the most likely diagnosis? Medscape Ophthalmology
Netarsudil Lowers IOP, but When Should It Be Given?
Findings from the ROCKET trials shed light on –and also raise questions about –this newly approved medication for glaucoma. Medscape Ophthalmology
Diet Soda Linked to Increased Risk for Diabetic Retinopathy
Diet soda, but not regular soda, was linked to increased risk for proliferative diabetic retinopathy, a study found; further studies are needed to confirm these findings. Medscape Medical News
Eric Topol’s Top Advances in 2018 That Are Shaping Medicine
Which advances in 2018 have the most potential to transform medicine? Dr Eric Topol shares his insights. Medscape
Medical Historian Prescribes, Fact Checks for Television
Who takes the call when Hollywood needs help with a medical script? In one case, the director of the Museum of Vision helped out, and plans to open to the public in 2020 are underway. Medscape Medical News
AMD Monitoring Comes Home: The Promise of Remote Tech
Current software helps track patients’ AMD progression. What’s coming next may enable us to intervene earlier with tailored treatments. Medscape Ophthalmology
Age-Related Macular Degeneration: 5 Things to Know
A guide to the latest on this chronic disease, from emerging treatments to the risk factors to be on the lookout for. Medscape Ophthalmology
Higher Eye Pressure After Anti-VEGF Therapy Needs More Attention
The elevated intraocular pressure (IOP) known to follow intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents may persist in certain patients, according to a report by the American Academy of Ophthalmology (AAO). Reuters He…
A Girl Whose Eyes Appear White in Photos
Photographs of this 6-year-old girl show ‘white eyes’ that concern her parents. What is your diagnosis? Medscape Ophthalmology
Does a Patient’s Blurry Vision Signal a Serious Condition?
Can you order the right diagnostic tests to determine what’s causing the woman’s optic neuritis? Medscape Neurology
Skipping Treatment for Diabetic Retinopathy Carries Risks
Drs Jason Hsu and Anthony Obeid on how the 25% of patients lost to follow-up are vulnerable to vision loss and other adverse outcomes. Wills Eye Hospital
What Do You Think About Retirement?
Is it healthier to retire or keep working? The answer may surprise you. Medscape Internal Medicine
FDA OKs Steroid Insert (Dextenza) for Postop Ocular Pain
Dextenza is the first FDA-approved intracanalicular insert that delivers dexamethasone to treat ocular pain following ophthalmic surgery for up to 30 days with a single insertion. FDA Approvals
EC OKs Gene Therapy Luxturna for Inherited Retinal Dystrophy
International Approvals